

Government of Canada invests in scientific and clinical hub for orphan drug developments
Researchers Seek New Drug Treatments for Rare Diseases September 13, 2016 - Halifax, N.S. – Atlantic Canada Opportunities Agency (ACOA) Rare diseases, as the name suggests, have small patient populations. Historically, these were “orphaned” by the pharmaceutical industry— leaving few approved drug treatment options for those with these “orphan diseases.” An innovative project underway at Dalhousie University is looking to change this, and the project is receiving an investmen